Nexium belongs to a class of antacids known as proton pump inhibitors or PPIs. With annual sales exceeding $10 billion, PPIs are generally considered safe for regular long-term use. For more than two decades, Nexium has been used by millions of people for gastroesophageal reflux, heartburn, and similar conditions associated with excess stomach acid. Critics say Nexium and other PPIs are greatly elevated, which is especially worrying given Nexium's cancer risk.
For every drug on the market, it is the manufacturer's responsibility to identify potential drug hazards and make consumers aware of them. With annual sales exceeding $22 billion, AstraZeneca had no reason not to explore Nexium's cancer potential last year. Currently, consumers suffering from Nexium cancer are trying to blame the global pharmaceutical giant for the failure by filing lawsuits against Nexium.
Given the very serious nature of litigation at Nexium, our company has devoted significant resources to ensuring the highest level of Nexium representation in the nation. Nexium lawyers believe filing Nexium lawsuits across the country is the best way to get the compensation they need for the people and families affected by Nexium cancer.
Image Source: Google
Unfortunately, the threat of major litigation is often needed to persuade pharmaceutical multinationals to make consumers better off. Our Nexium cancer attorneys are committed to providing compensation for the pain, suffering, and cost of illness, no matter how complex it may be.
Frequently asked questions about Nexium Trial:
This section has been compiled by our Nexium Litigation team and provides answers to frequently asked questions about filing a Nexium case for stomach cancer, esophageal cancer, or liver cancer. If you have any questions after reading this list of Nexium FAQs, our lawyers are always available to discuss your situation.